Global Narcolepsy Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Narcolepsy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Narcolepsy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Polysomnogram
  • 1.4.3 Multiple Sleep Latency Test
• 1.5 Market by Application
  • 1.5.1 Global Narcolepsy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Retail Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Narcolepsy Market Perspective (2015-2026)
• 2.2 Global Narcolepsy Growth Trends by Regions
  • 2.2.1 Narcolepsy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Narcolepsy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Narcolepsy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Narcolepsy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Narcolepsy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Narcolepsy Players by Market Size
  • 3.1.1 Global Top Narcolepsy Players by Revenue (2015-2020)
  • 3.1.2 Global Narcolepsy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Narcolepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Narcolepsy Market Concentration Ratio
  • 3.2.1 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Revenue in 2019
• 3.3 Narcolepsy Key Players Head office and Area Served
• 3.4 Key Players Narcolepsy Product Solution and Service
• 3.5 Date of Enter into Narcolepsy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Narcolepsy Historic Market Size by Type (2015-2020)
• 4.2 Global Narcolepsy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Narcolepsy Market Size by Application (2015-2020)
• 5.2 Global Narcolepsy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Narcolepsy Market Size (2015-2020)
• 6.2 Narcolepsy Key Players in North America (2019-2020)
• 6.3 North America Narcolepsy Market Size by Type (2015-2020)
• 6.4 North America Narcolepsy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Narcolepsy Market Size (2015-2020)
• 7.2 Narcolepsy Key Players in Europe (2019-2020)
• 7.3 Europe Narcolepsy Market Size by Type (2015-2020)
• 7.4 Europe Narcolepsy Market Size by Application (2015-2020)

8 China

• 8.1 China Narcolepsy Market Size (2015-2020)
• 8.2 Narcolepsy Key Players in China (2019-2020)
• 8.3 China Narcolepsy Market Size by Type (2015-2020)
• 8.4 China Narcolepsy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Narcolepsy Market Size (2015-2020)
• 9.2 Narcolepsy Key Players in Japan (2019-2020)
• 9.3 Japan Narcolepsy Market Size by Type (2015-2020)
• 9.4 Japan Narcolepsy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Narcolepsy Market Size (2015-2020)
• 10.2 Narcolepsy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Narcolepsy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Narcolepsy Market Size by Application (2015-2020)

11 India

• 11.1 India Narcolepsy Market Size (2015-2020)
• 11.2 Narcolepsy Key Players in India (2019-2020)
• 11.3 India Narcolepsy Market Size by Type (2015-2020)
• 11.4 India Narcolepsy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Narcolepsy Market Size (2015-2020)
• 12.2 Narcolepsy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Narcolepsy Market Size by Type (2015-2020)
• 12.4 Central & South America Narcolepsy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Jazz Pharmaceuticals
  • 13.1.1 Jazz Pharmaceuticals Company Details
  • 13.1.2 Jazz Pharmaceuticals Business Overview
  • 13.1.3 Jazz Pharmaceuticals Narcolepsy Introduction
  • 13.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2015-2020))
  • 13.1.5 Jazz Pharmaceuticals Recent Development
• 13.2 Bioprojet
  • 13.2.1 Bioprojet Company Details
  • 13.2.2 Bioprojet Business Overview
  • 13.2.3 Bioprojet Narcolepsy Introduction
  • 13.2.4 Bioprojet Revenue in Narcolepsy Business (2015-2020)
  • 13.2.5 Bioprojet Recent Development
• 13.3 Arena Pharmaceuticals
  • 13.3.1 Arena Pharmaceuticals Company Details
  • 13.3.2 Arena Pharmaceuticals Business Overview
  • 13.3.3 Arena Pharmaceuticals Narcolepsy Introduction
  • 13.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
  • 13.3.5 Arena Pharmaceuticals Recent Development
• 13.4 Graymark Healthcare
  • 13.4.1 Graymark Healthcare Company Details
  • 13.4.2 Graymark Healthcare Business Overview
  • 13.4.3 Graymark Healthcare Narcolepsy Introduction
  • 13.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2015-2020)
  • 13.4.5 Graymark Healthcare Recent Development
• 13.5 Mylan
  • 13.5.1 Mylan Company Details
  • 13.5.2 Mylan Business Overview
  • 13.5.3 Mylan Narcolepsy Introduction
  • 13.5.4 Mylan Revenue in Narcolepsy Business (2015-2020)
  • 13.5.5 Mylan Recent Development
• 13.6 Teva Pharmaceutical Industries
  • 13.6.1 Teva Pharmaceutical Industries Company Details
  • 13.6.2 Teva Pharmaceutical Industries Business Overview
  • 13.6.3 Teva Pharmaceutical Industries Narcolepsy Introduction
  • 13.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2015-2020)
  • 13.6.5 Teva Pharmaceutical Industries Recent Development
• 13.7 Novartis
  • 13.7.1 Novartis Company Details
  • 13.7.2 Novartis Business Overview
  • 13.7.3 Novartis Narcolepsy Introduction
  • 13.7.4 Novartis Revenue in Narcolepsy Business (2015-2020)
  • 13.7.5 Novartis Recent Development
• 13.8 Takeda
  • 13.8.1 Takeda Company Details
  • 13.8.2 Takeda Business Overview
  • 13.8.3 Takeda Narcolepsy Introduction
  • 13.8.4 Takeda Revenue in Narcolepsy Business (2015-2020)
  • 13.8.5 Takeda Recent Development
• 13.9 Shionogi
  • 13.9.1 Shionogi Company Details
  • 13.9.2 Shionogi Business Overview
  • 13.9.3 Shionogi Narcolepsy Introduction
  • 13.9.4 Shionogi Revenue in Narcolepsy Business (2015-2020)
  • 13.9.5 Shionogi Recent Development
• 13.10 Ligand Pharmaceuticals
  • 13.10.1 Ligand Pharmaceuticals Company Details
  • 13.10.2 Ligand Pharmaceuticals Business Overview
  • 13.10.3 Ligand Pharmaceuticals Narcolepsy Introduction
  • 13.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
  • 13.10.5 Ligand Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer